USCWA
U.S. Capital Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.01M | Buy |
81,228
+75,078
| +1,221% | +$8.32M | 0.26% | 99 |
|
2025
Q1 | $689K | Sell |
6,150
-555
| -8% | -$62.2K | 0.02% | 508 |
|
2024
Q4 | $619K | Sell |
6,705
-64,693
| -91% | -$5.98M | 0.02% | 518 |
|
2024
Q3 | $5.99M | Sell |
71,398
-4,373
| -6% | -$367K | 0.21% | 110 |
|
2024
Q2 | $5.2M | Sell |
75,771
-4,003
| -5% | -$275K | 0.2% | 113 |
|
2024
Q1 | $5.84M | Sell |
79,774
-3,296
| -4% | -$241K | 0.22% | 108 |
|
2023
Q4 | $6.73M | Buy |
83,070
+63,009
| +314% | +$5.1M | 0.27% | 92 |
|
2023
Q3 | $1.5M | Sell |
20,061
-2,733
| -12% | -$205K | 0.07% | 249 |
|
2023
Q2 | $1.76M | Sell |
22,794
-2,901
| -11% | -$224K | 0.08% | 236 |
|
2023
Q1 | $2.13M | Sell |
25,695
-528
| -2% | -$43.8K | 0.1% | 195 |
|
2022
Q4 | $2.25M | Sell |
26,223
-84,928
| -76% | -$7.29M | 0.1% | 188 |
|
2022
Q3 | $6.86M | Sell |
111,151
-645
| -0.6% | -$39.8K | 0.35% | 63 |
|
2022
Q2 | $6.91M | Buy |
111,796
+890
| +0.8% | +$55K | 0.3% | 68 |
|
2022
Q1 | $6.59M | Sell |
110,906
-544
| -0.5% | -$32.3K | 0.24% | 88 |
|
2021
Q4 | $8.09M | Sell |
111,450
-14,516
| -12% | -$1.05M | 0.32% | 74 |
|
2021
Q3 | $8.76M | Buy |
+125,966
| New | +$8.76M | 0.38% | 60 |
|